Zeppenfeld K, Tfelt-Hansen J, de Riva M et al (2022) ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 43(40):3997–4126
Cronin EM, Bogun FM, Maury P et al (2019) 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Europace 21(8):1143–1144. https://doi.org/10.1093/europace/euz132 (Erratum in: Europace. 2019 Aug 1;21(8):1144. Erratum in: J Arrhythm. 2020 Jan 12;36(1):214. Erratum in: Europace. 2020 Mar 1;22(3):505)
Article PubMed PubMed Central Google Scholar
Kapa S, Gaba P, DeSimone CV et al (2017) Fascicular ventricular arrhythmias: pathophysiologic mechanisms, anatomical constructs, and advances in approaches to management. Circ Arrhythm Electrophysiol 10(1):e2476
Heeger CH, Hayashi K, Kuck KH et al (2016) Catheter ablation of idiopathic ventricular arrhythmias arising from the cardiac outflow tracts—recent insights and techniques for the successful treatment of common and challenging cases. Circ J 80(5):1073–1086
Liao Z, Zhan X, Wu S et al (2015) Idiopathic ventricular arrhythmias originating from the pulmonary sinus cusp: prevalence, electrocardiographic/electrophysiological characteristics, and catheter ablation. J Am Coll Cardiol 66(23):2633–2644
Wissner E, Menon SY, Metzner A et al (2012) Long-term outcome after catheter ablation for left posterior fascicular ventricular tachycardia without development of left posterior fascicular block. J Cardiovasc Electrophysiol 23(11):1179–1184
Mathew S, Fink T, Feickert S et al (2022) Complications and mortality after catheter ablation of ventricular arrhythmias: risk in VT ablation (RIVA) score. Clin Res Cardiol 111(5):530–540
Fink T, Sciacca V, Feickert S et al (2020) Outcome of cardiac tamponades in interventional electrophysiology. Europace 22(8):1240–1251
Ventura R, Steven D, Klemm HU, Lutomsky B, Müllerleile K, Rostock T, Servatius H, Risius T, Meinertz T, Kuck KH, Willems S (2007) Decennial follow-up in patients with recurrent tachycardia originating from the right ventricular outflow tract: electrophysiologic characteristics and response to treatment. Eur Heart J 28(19):2338–2345. https://doi.org/10.1093/eurheartj/ehm293
Hayashi T, Liang JJ, Shirai Y, Kuo L, Muser D, Kubala M, Kumareswaran R, Arkles JS, Garcia FC, Supple GE, Schaller RD, Frankel DS, Riley MP, Lin D, Santangeli P, Zado ES, Callans DJ, Marchlinski FE, Dixit S (2020) Trends in successful ablation sites and outcomes of ablation for idiopathic outflow tract ventricular arrhythmias. JACC Clin Electrophysiol 6(2):221–230. https://doi.org/10.1016/j.jacep.2019.10.004
de Vries LJ, Hendriks AA, Yap SC, Theuns DAMJ, van Domburg RT, Szili-Torok T (2018) Procedural and long-term outcome after catheter ablation of idiopathic outflow tract ventricular arrhythmias: comparing manual, contact force, and magnetic navigated ablation. Europace 20(suppl_2):ii22–ii27. https://doi.org/10.1093/europace/euy004
Stevenson WG, Khan H, Sager P et al (1993) Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 88(4 Pt 1):1647–1670
Article CAS PubMed Google Scholar
de Bakker JM, van Capelle FJ, Janse MJ et al (1993) Slow conduction in the infarcted human heart. ‘Zigzag’ course of activation. Circulation 88(3):915–926
Koplan BA, Soejima K, Baughman K et al (2006) Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation. Heart Rhythm 3(8):924–929
Zeppenfeld K, Schalij MJ, Bartelings MM et al (2007) Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus. Circulation 116(20):2241–2252
Article CAS PubMed Google Scholar
Nakahara S, Tung R, Ramirez RJ et al (2010) Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia. J Am Coll Cardiol 55(21):2355–2365
Article PubMed PubMed Central Google Scholar
Hsia HH, Callans DJ, Marchlinski FE (2003) Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation 108(6):704–710
Arenal A, Glez-Torrecilla E, Ortiz M et al (2003) Ablation of electrograms with an isolated, delayed component as treatment of unmappable monomorphic ventricular tachycardias in patients with structural heart disease. J Am Coll Cardiol 41(1):81–92
Cochet H, Komatsu Y, Sacher F et al (2013) Integration of merged delayed-enhanced magnetic resonance imaging and multidetector computed tomography for the guidance of ventricular tachycardia ablation: a pilot study. J Cardiovasc Electrophysiol 24(4):419–426
Andreu D, Berruezo A, Ortiz-Pérez JT et al (2011) Integration of 3D electroanatomic maps and magnetic resonance scar characterization into the navigation system to guide ventricular tachycardia ablation. Circ Arrhythm Electrophysiol 4(5):674–683
van Huls van Taxis CF, Wijnmaalen AP et al (2013) Real-time integration of MDCT-derived coronary anatomy and epicardial fat: impact on epicardial electroanatomic mapping and ablation for ventricular arrhythmias. JACC Cardiovasc Imaging 6(1):42–52
Sasaki T, Miller CF, Hansford R et al (2012) Myocardial structural associations with local electrograms: a study of postinfarct ventricular tachycardia pathophysiology and magnetic resonance-based noninvasive mapping. Circ Arrhythm Electrophysiol 5(6):1081–1090
Article PubMed PubMed Central Google Scholar
Bogun FM, Desjardins B, Good E et al (2009) Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate. J Am Coll Cardiol 53(13):1138–1145
Article PubMed PubMed Central Google Scholar
Abbara S, Desai JC, Cury RC et al (2006) Mapping epicardial fat with multi-detector computed tomography to facilitate percutaneous transepicardial arrhythmia ablation. Eur J Radiol 57(3):417–422
Reddy VY, Reynolds MR, Neuzil P et al (2007) Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 357(26):2657–2665
Article CAS PubMed PubMed Central Google Scholar
Kuck KH, Schaumann A, Eckardt L et al (2010) Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 375(9708):31–40
Kuck KH, Tilz RR, Deneke T et al (2017) Impact of substrate modification by catheter ablation on implantable cardioverter-defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (substrate modification study). Circ Arrhythm Electrophysiol 10(3):e4422
Al-Khatib SM, Daubert JP, Anstrom KJ, Daoud EG, Gonzalez M, Saba S, Jackson KP, Reece T, Gu J, Pokorney SD, Granger CB, Hess PL, Mark DB, Stevenson WG (2015) Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial. J Cardiovasc Electrophysiol. 26(2):151–157. https://doi.org/10.1111/jce.12567
Sapp JL, Wells GA, Parkash R et al (2016) Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med 375(2):111–121
Article CAS PubMed Google Scholar
Willems S, Tilz RR, Steven D et al (2020) Preventive or deferred ablation of ventricular tachycardia in patients with Ischemic cardiomyopathy and implantable defibrillator (BERLIN VT): a multicenter randomized trial. Circulation 141(13):1057–1067
Arenal Á, Ávila P, Jiménez-Candil J et al (2022) Substrate ablation vs Antiarrhythmic drug therapy for symptomatic ventricular tachycardia. J Am Coll Cardiol 79(15):1441–1453
Article CAS PubMed Google Scholar
Della Bella P, Baratto F, Vergara P et al (2022) Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? Results from the multicenter randomized PARTITA trial. Circulation 145(25):1829–1838
Article CAS PubMed Google Scholar
Tung R, Xue Y, Chen M et al (2022) First-line catheter ablation of monomorphic ventricular tachycardia in cardiomyopathy concurrent with defibrillator implantation: the PAUSE-SCD randomized trial. Circulation 145(25):1839–1849
Article CAS PubMed Google Scholar
Dinov B, Fiedler L, Schönbauer R et al (2014) Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study. Circulation 129(7):728–736
Chakarov I, Mueller J, Ene E, Berkovitz A, Sonne K, Nentwich K, Schupp T, Behnes M, Deneke T (2022) Long-term outcomes after catheter ablation of ventricular tachycardia in dilated vs. ischemic cardiomyopathy. J Clin Med 11(14):4000. https://doi.org/10.3390/jcm11144000
Article PubMed PubMed Central Google Scholar
Kumar S, Romero J, Mehta NK, Fujii A, Kapur S, Baldinger SH, Barbhaiya CR, Koplan BA, John RM, Epstein LM, Michaud GF, Tedrow UB, Stevenson WG (2016) Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease. Heart Rhythm 13(10):1957–1963. https://doi.org/10.1016/j.hrthm.2016.07.001
Comments (0)